Skip to search formSkip to main contentSkip to account menu

lipase inhibitor

Known as: inhibitors lipase 
National Institutes of Health

Related topics

Related topics

1 relation
Lipase Inhibitors [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The Impact of Life-style Drugs on Society: An Empirical Evidence from Pattaya, Thailand
People are extensively using drugs for changing their physical and mental aptitudes. These drugs are called life-style drugs… 
2017
2017
Chitosan dosage regimen to trap fecal oil excretion after peroral lipase inhibitor administration in mice.
Review
2016
Review
2016
Weight management in obesity – past and present
To describe the treatment of obesity from ancient times to present day. 
2014
2014
Development of a bioautographic method for the detection of lipase inhibitors.
2010
2010
Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus
Abstract To develop a potent anti-obesity lipase inhibitor from mushroom, the lipase inhibitory activities of various mushroom… 
2005
2005
An agent for the prophylaxis or treatment of a lipase inhibitor and skin diseases
The present invention is directed to "proanthocyanidin" or "cranberry extract containing proanthocyanidins" the active ingredient… 
2001
2001
Role of Nonesterified Fatty Acids in Necrotizing Pancreatitis: An In Vivo Experimental Study in Rats
Introduction In acute pancreatitis, nonesterified fatty acids (NEFA) might be released by lipase and cause tissue necrosis by… 
1998
1998
Orlistat F Hoffmann-La Roche Ltd.
  • M. Malone
  • IDrugs : the investigational drugs journal
  • 1998
  • Corpus ID: 45993743
Orlistat (Xenical) is a lipase inhibitor developed by Roche for the treatment of obesity, which has been approved in New Zealand… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)